Pharmacodynamics and pharmacokinetics of eptifibatide in patients with acute coronary syndromes: Prospective analysis from PURSUIT Academic Article uri icon

Overview

MeSH Major

  • Angina, Unstable
  • Peptides
  • Platelet Aggregation Inhibitors

abstract

  • A bolus and infusion of eptifibatide inhibits platelet aggregation profoundly in patients with ACS and is followed by brief, partial recovery. These results enhance our understanding of the relation between pharmacodynamic and clinical effects of eptifibatide in such patients and may have important implications for its use in percutaneous interventions.

publication date

  • July 24, 2001

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed ID

  • 11468200

Additional Document Info

start page

  • 399

end page

  • 405

volume

  • 104

number

  • 4